Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
N
Shared by NobleBlocks on May 16, 2024 • 12:00 AM UTC
Authors:
J. Cortes
,
Koiji Sasaki
,
Dong-Wook Kim
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results | NobleBlocks
